This is the "real deal"! And Caracciolo was responsible for the acquisition of Prostagene.
But I think it's still worth holding. Way too many positive catalysts right now. I would say the change in management is really what I'm hanging my hat on! This dude is the "real deal"
And then he was terminated for incompetency how many month's later?